BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 10687280)

  • 1. Optimization of tumour radiotherapy: Part V--Radiosensitization by 2-deoxy-D-glucose and DNA ligand Hoechst-33342 in a murine tumour.
    Dwarakanath BS; Singh S; Jain V
    Indian J Exp Biol; 1999 Sep; 37(9):865-70. PubMed ID: 10687280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiosensitization of murine Ehrlich ascites tumor by a combination of 2-deoxy-D-glucose and 6-aminonicotinamide.
    Varshney R; Gupta S; Dwarakanath BS
    Technol Cancer Res Treat; 2004 Dec; 3(6):659-63. PubMed ID: 15560724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hematoporphyrin derivatives potentiate the radiosensitizing effects of 2-deoxy-D-glucose in cancer cells.
    Dwarakanath BS; Adhikari JS; Jain V
    Int J Radiat Oncol Biol Phys; 1999 Mar; 43(5):1125-33. PubMed ID: 10192364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radioprotective effects of DNA ligands Hoechst-33342 and 33258 in whole body irradiated mice.
    Singh SP; Jayanth VR; Chandna S; Dwarakanath BS; Singh S; Adhikari JS; Jain V
    Indian J Exp Biol; 1998 Apr; 36(4):375-84. PubMed ID: 9717448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced antitumor immunity contributes to the radio-sensitization of ehrlich ascites tumor by the glycolytic inhibitor 2-deoxy-D-glucose in mice.
    Farooque A; Singh N; Adhikari JS; Afrin F; Dwarakanath BS
    PLoS One; 2014; 9(9):e108131. PubMed ID: 25248151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The glycolytic inhibitor 2-deoxy-D-glucose enhances the efficacy of etoposide in ehrlich ascites tumor-bearing mice.
    Gupta S; Mathur R; Dwarakanath BS
    Cancer Biol Ther; 2005 Jan; 4(1):87-94. PubMed ID: 15711125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential modification of radiation damage in 5-bromo-2-deoxy-uridine sensitized human glioma cells and PHA-stimulated peripheral leukocytes by 2-deoxy-D-glucose.
    Kalia VK; Devi NK
    Indian J Exp Biol; 1994 Sep; 32(9):637-42. PubMed ID: 7814043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experimental evaluation of the glucose antimetabolite, 2-deoxy-D-glucose (2-DG) as a possible adjuvant to radiotherapy of tumors: I. Kinetics of growth and survival of Ehrlich ascites tumor cells (EATC) in vitro and of growth of solid tumors after 2-DG and X-irradiation.
    Purohit SC; Pohlit W
    Int J Radiat Oncol Biol Phys; 1982; 8(3-4):495-9. PubMed ID: 7107374
    [No Abstract]   [Full Text] [Related]  

  • 9. Polarization of macrophages towards M1 phenotype by a combination of 2-deoxy-d-glucose and radiation: Implications for tumor therapy.
    Farooque A; Afrin F; Adhikari JS; Dwarakanath BS
    Immunobiology; 2016 Feb; 221(2):269-81. PubMed ID: 26597503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiosensitization by 6-aminonicotinamide and 2-deoxy-D-glucose in human cancer cells.
    Varshney R; Dwarakanath B; Jain V
    Int J Radiat Biol; 2005 May; 81(5):397-408. PubMed ID: 16076755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimizing radiation therapy of brain tumours by combination of 5-bromo-2-deoxy-uridine & 2-deoxy-D-glucose.
    Kalia VK
    Indian J Med Res; 1999 May; 109():182-7. PubMed ID: 10643143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimization of tumor radiotherapy. Part VI: Modification of tumor glucose metabolism for increasing the bioavailability of 2-deoxy-D-glucose (2-DG) in a murine tumor model.
    Sharma RK; Singh S; Degaonkar M; Raghunathan P; Maitra A; Jain V
    Strahlenther Onkol; 2000 Mar; 176(3):135-43. PubMed ID: 10742835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preliminary investigation of the radiosensitizing activity of guduchi (Tinospora cordifolia) in tumor-bearing mice.
    Rao SK; Rao PS; Rao BN
    Phytother Res; 2008 Nov; 22(11):1482-9. PubMed ID: 18803246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potentiation of radiation effects in plateau phase human glioma cells by combination of metabolic inhibitors.
    Kalia VK
    Indian J Exp Biol; 1993 Apr; 31(4):312-5. PubMed ID: 8359829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiosensitization of tumours by porphyrins.
    Luksiene Z; Juzenas P; Moan J
    Cancer Lett; 2006 Apr; 235(1):40-7. PubMed ID: 15946797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycolytic inhibitor, 2-deoxy-D-glucose, does not enhance radiation-induced apoptosis in mouse thymocytes and splenocytes in vitro.
    Swamy RK; Manickam J; Adhikari JS; Dwarakanath BS
    Indian J Exp Biol; 2005 Aug; 43(8):686-92. PubMed ID: 16121709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimization of cancer therapy: Part I--Inhibition of repair of x-ray induced potentially lethal damage by 2-deoxy-D-glucose in Ehrlich-ascites tumour cells.
    Jain VK; Purohit SC; Pohlit W
    Indian J Exp Biol; 1977 Sep; 15(9):711-3. PubMed ID: 611088
    [No Abstract]   [Full Text] [Related]  

  • 18. Contribution of oxidative stress to radiosensitization by a combination of 2-DG and 6-AN in human cancer cell line.
    Varshney R; Adhikari JS; Dwarakanath BS
    Indian J Exp Biol; 2003 Dec; 41(12):1384-91. PubMed ID: 15320490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytotoxicity, radiosensitization, and chemosensitization of tumor cells by 2-deoxy-D-glucose in vitro.
    Dwarakanath BS
    J Cancer Res Ther; 2009 Sep; 5 Suppl 1():S27-31. PubMed ID: 20009290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of cellular radiation responses by 2-deoxy-D-glucose and other glycolytic inhibitors: implications for cancer therapy.
    Kalia VK; Prabhakara S; Narayanan V
    J Cancer Res Ther; 2009 Sep; 5 Suppl 1():S57-60. PubMed ID: 20009297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.